New hepatitis C drugs could completely eradicate the virus

by Nicky Pellegrino / 04 December, 2017
RelatedArticlesModule - Hepatitis C drugs treatment

A computer illustration of the destruction of a hepatitis C virus. Photo/Getty Images

For hepatitis C sufferers, new drugs could make the difference between life and death.

Hepatitis C results in more deaths worldwide than malaria, HIV or TB, but there’s good news about this blood-borne virus, which can lead to liver cancer or cirrhosis. We now have drugs to cure it, and there’s no reason we shouldn’t meet the World Health Organisation’s goal of complete elimination by 2030. We just have to get on with it, says Dr Homie Razavi.

He is the managing director of the Colorado-based Center for Disease Analysis (CDA), a public health research firm that has analysed hepatitis epidemiology in more than 100 countries, including New Zealand.

In this country, the problem seems relatively small, with about 25,000 diagnosed hepatitis C sufferers. However, it’s estimated that another 25,000 aren’t showing symptoms, so haven’t been tested. And even those who are aware they are carrying the virus can be slow to seek treatment until they become seriously ill.

Worldwide, about 71 million people are infected with hepatitis C. The main mode of infection in New Zealand was blood transfusions and medical procedures before 1992.After that, the markers of the virus were identified and the blood supply screened. The heroin epidemic of the Mr Asia years also had a big impact.

Previously, the most common treatment was interferon therapy – an expensive and drawn-out procedure with bad side effects. Now, a new generation of direct-acting anti-viral drugs offer a 90% cure rate, with few side effects and shorter treatment times. The only remaining challenge is to identify sufferers and make sure they get treatment.

Dr Homie Razavi.

This should be happening faster, says Razavi. “To me, it’s baffling. When we started working in this field, we looked at the disease and what was coming down the pipeline and thought, ‘This is a done deal, we can do this in five years.’”

Part of the problem appears to be some doctors’ reluctance to prescribe treatment for a slow-progressing illness that doesn’t necessarily result in cancer or cirrhosis and can, in some cases, be beaten by the body’s own immune system.

But it’s still a serious disease. Liver cancer is one of the leading causes of cancer deaths worldwide and is on the rise. “If this was any other cancer-causing virus, we’d have dealt with it immediately. I don’t know why hepatitis is any different,” Razavi says.

As a result of funding issues, the latest drugs are being rolled out gradually in New Zealand. Two have been available since 2016: Harvoni for those with severe liver disease and Viekira Pak for those with the most common strain of the virus. Six distinct genotypes have been identified, which means we’ve still got gaps, but Pharmac is talking to drug companies with a view to expanding treatment.

It helps that the CDA has made a financial case for investing in these drugs – with the cost at under $10,000 a person in this country. “The cost of doing nothing is substantially higher, even though not everyone develops liver cancer or cirrhosis,” says Razavi.

So far, 2000 New Zealanders have been treated with the new drugs. But that number needs to rise to about 5000 a year if the 2030 deadline is to be met. Razavi urges those who think they may have been exposed to get tested as soon as possible. More at risk are people who have had a piercing or tattoo using unsterile equipment or received medical treatment in a high-risk area such as South-east Asia or eastern Europe. Although sufferers often have no symptoms for years, unusual fatigue, joint pain, loss of appetite, nausea and abdominal pain are the most common symptoms.

“If you have the virus, there is potential for contaminating and infecting others, so if you test positive, ask for treatment,” says Razavi.

In the past, we’ve successfully controlled other once-common diseases through vaccination. “But this is completely new,” he says. “It’s the first one where we’re saying we’re going to use a curative therapy to eradicate the disease, and history isn’t going to be kind to us if we don’t do this right.”

This article was first published in the October 21, 2017 issue of the New Zealand Listener.

MostReadArticlesCollectionWidget - Most Read - Used in articles
AdvertModule - Advert - M-Rec / Halfpage

Latest

How to lose weight without a diet
87141 2018-02-25 00:00:00Z Nutrition

How to lose weight without a diet

by Jennifer Bowden

"The irony is the intentional pursuit of weight loss – dieting, in other words – is actually a predictor of future weight gain."

Read more
Baby boomers are rethinking retirement for a later-life reboot
87313 2018-02-24 00:00:00Z Social issues

Baby boomers are rethinking retirement for a later…

by Sally Blundell

The biggest cohort of baby boomers is reaching retirement age – and many are not planning a quiet dotage.

Read more
School shootings and Russian indictments
87455 2018-02-24 00:00:00Z World

School shootings and Russian indictments

by Joanne Black

Slaughter in a school and Russian social-media mischief: the US is under siege.

Read more
Beck to go back to basics at Auckland City Limits
87417 2018-02-24 00:00:00Z Profiles

Beck to go back to basics at Auckland City Limits

by James Belfield

Before headlining Auckland City Limits, Beck talks about celebrating his musical past on stage and on record.

Read more
Islands of the Gulf: How the Hauraki has changed
87427 2018-02-24 00:00:00Z Television

Islands of the Gulf: How the Hauraki has changed

by Fiona Rae

A broadcaster revisits her mother’s iconic Islands of the Gulf TV series to see what’s changed since the 60s.

Read more
Hokianga's Wild West fest's unusual way of fundraising
86388 2018-02-24 00:00:00Z Life in NZ

Hokianga's Wild West fest's unusual way of fundrai…

by Peter De Graaf

Once a year, the Wild West saddles up and rides into Waimamaku for a day of highway robbery.

Read more
Back on track: $60m to go into regional rail
87519 2018-02-23 14:43:30Z Economy

Back on track: $60m to go into regional rail

by Jane Patterson

Five regions will receive just over $60 million for rebooting rail in the first chunk of money from the Provincial Growth Fund.

Read more
Ricky Houghton is about finding innovative solutions to the issues facing Māori
87510 2018-02-23 14:21:31Z Profiles

Ricky Houghton is about finding innovative solutio…

by Clare de Lore

No government on their own can fix the problems facing Māori in the Far North, warns Local Hero of the Year Ricky Houghton.

Read more